About ACC

Specializing in chromogenic and turbidimetric reagent technologies, Associates of Cape Cod, Inc. (ACC) has been a global leader in endotoxin and (1→3)-β-D-glucan detection products and services for 50 years. ACC pioneered LAL testing methodology and was the first FDA-licensed company to manufacture LAL reagents; ACC has grown to be an internationally recognized leader in endotoxin detection.

Our worldwide headquarters are in East Falmouth, Massachusetts. With a dedication to quality, ACC is certified to I.S. EN ISO 13485:2016 and ISO 13485:2016. We are FDA-inspected and operate DEA-licensed and CLIA-certified laboratories. Our endotoxin detection reagents, instruments, and software are used within the pharmaceutical, medical device, biotechnology, compounding pharmacy, and dialysis industries for quality control, product release, and research. Our reagents are FDA-licensed and can be used for testing in compliance with USP, EP, and JP bacterial endotoxin test chapters, and our software is 21 CFR Part 11 Compliant.

ACC also operates a Contract Test Services (CTS) Laboratory, which has specialized in testing for endotoxin and glucan contamination for over 30 years. Our CTS laboratory is GMP-compliant, ISO-registered, and DEA-licensed and can handle all controlled drug substances except those included in Schedule 1. All testing services can be performed to FDA, USP, EP, and/or JP regulatory guidelines. In addition to routine testing, our CTS Laboratory will customize endotoxin testing, troubleshoot difficult samples, develop and/or transfer LAL test methods, design and produce custom depyrogenation controls for oven validation, and perform low endotoxin recovery (LER) studies/protocols.

ACC also offers a clinical diagnostic product line and operates a CLIA-certified laboratory specializing in (1→3)-β-D-glucan analysis to support the diagnosis of invasive fungal infections (IFI).